| Century Therapeutics
Biotechnology · Cell & Gene Therapy
Sponsors visas
2Open roles
$210kMedian advertised pay$150k – $150k
Lately:6 news stories in 90 daysFollow changes →
Facts
as of Nov 17, 2026Century Therapeutics is on a mission to develop innovative allogeneic, iPSC-derived NK and T cell therapies that are more effective, tolerable, accessible, and affordable versus existing cells therapies.
It is hiring: 2 open roles, 0 of them posted in the last 30 days.
- Open roles
- 2 in 3 citiesAlion job postings
- Official records
- Wikidata Q107519701SEC CIK 1850119
- Website
- centurytx.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring
All open roles →Hiring slowly: few roles were posted lately.
Leadership is the largest family, 33 of open roles.
0%Remote roles0 of 2
3Hiring offices
Can they hire you from United States?by your location
Likely
3 open roles are in your country: you apply locally, no move needed.
No posting offers visa sponsorship. Remote roles: 0.
Alion signals0-100
Demand4
Pay21
Your chance35
How badly they need people, whether they pay, how realistic getting in is.
Where the openings areshare of open roles · trend
Degree asked
Doctoral Degree (PhD) 100%
1 postings state a degree.
Benefits named in postingsshare of open roles
Contract type
Full-Time 2
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Pay
What its postings pay, by level.
$210kMedian
$150k – $150kTypical rangeUSD a year
$270kHighest paying roleSenior Director, Clinical Operations
Source: the pay stated in the company's postings, normalised to USD a year
Visa
Full chapter →Named in the work visa registers of United States.
0H-1B filings in 12 months
0Open roles in United States
In the register as Century Therapeutics, Inc., Philadelphia, PA
Other sponsors in the same field
Alert me
US Department of Labor · latest filing Apr 24, 2025
Footprint
Hiring in 3 cities in 1 country.
3Cities
1Countries
Loading the map
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Branchburg United States | Regional office | 0 | ||
| Philadelphia United States | Regional office | 0 | ||
| Boston United States | Regional office | 0 |
Source: office addresses in postings and company registers
Tech stack
Technologies named in job postings at | Century Therapeutics over the last 12 months, by layer, with the share of postings for each.
7Technologies in use
2Postings analysed
52/100Stack modernity
Cloud & platformsGCP
Practices & domainsBioreactorsCell CultureDesign of ExperimentsFlow CytometryGLPGMP
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Newsroom
Sep 242026
News · Century Therapeutics stock falls 6.88 percent as milestones approach
Century Therapeutics stock traded at USD 1.76 on September 23, 2026, 42.1 percent below its 52-week high. Q2 EPS was USD -0.17 versus USD -0.11 consensus.
Sep 202026
News · Century Therapeutics stock extends strong run as IPSC jumps over 700 percent in 12 months
Century Therapeutics stock has gained about 701.1 percent in market capitalization over the past 12 months as of September 18, 2026. The IPSC share price recently stood near USD…
Sep 162026
Sep 162026
Sep 102026
Press release · The Globe and Mail
Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.
Sep 102026
News · markets.businessinsider.com
PHILADELPHIA, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. ('Century', NASDAQ: IPSC), a biotechnology company developing induce...
Sources: the outlets named on each headline, each story once
